Characterization of poxtA, a novel phenicol–oxazolidinone–tetracycline resistance gene from an MRSA of clinical origin | Zendy

Alberto Antonelli | Zendy; Marco Maria D’Andrea | Zendy; Andrea Brenciani | Zendy; Cesira L. Galeotti | Zendy; Gianluca Morroni | Zendy; Simona Pollini | Zendy; Pietro E. Varaldo | Zendy; Gian María Rossolini | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Characterization of poxtA, a novel phenicol–oxazolidinone–tetracycline resistance gene from an MRSA of clinical origin

Author(s) -

Alberto Antonelli,

Marco Maria D’Andrea,

Andrea Brenciani,

Cesira L. Galeotti,

Gianluca Morroni,

Simona Pollini,

Pietro E. Varaldo,

Gian María Rossolini

Publication year - 2018

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dky088

Subject(s) - biology , enterococcus faecalis , enterococcus faecium , genetics , microbiology and biotechnology , gene , transposable element , tetracycline , linezolid , context (archaeology) , staphylococcus aureus , genome , escherichia coli , antibiotics , vancomycin , bacteria , paleontology

To characterize a novel phenicol-oxazolidinone-tetracycline resistance gene, named poxtA, identified in a previously described MRSA strain that was highly resistant to linezolid and also carried the cfr gene.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research